Form 4 for DGX Quest Diagnostics
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001022079-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-04 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $173.74 | +8,549 | 46.7K | +22% | +$1.49M | |
| 2025-03-05 | 2025-03-04 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $175.79 | -592 | 38.1K | -2% | -$104.1K | |
| M | 2025-03-05 | 2025-03-03+ | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $173.74 | -4,228 | 42.8K | -9% | -$734.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | A | A | 8,549 | $173.74 | 46,666 | D | — | — | (F3) Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award dated approved in accordance with the requirements of Rule 16b-3(d). |
| 2 | Common | Common Stock | 2025-03-04 | S | D | 592 | $175.79 | 38,117 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-03 | F | D | 322 | $173.74 | 38,709 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 4 | Common | Common Stock | 2025-03-04 | F | D | 3,906 | $173.74 | 42,760 | D | — | — | (F4) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. |